MedTrace Logo

Reduction of Obesity-Associated Intestinal Inflammation by Low-Fat Dairy Yogurt

NCT01686204 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 128

Last updated 2017-10-03

No results posted yet for this study

Summary

The main objective of this work is to conduct a clinical trial in obese and non-obese individuals testing the ability of low-fat dairy yogurt to improve gastrointestinal health and reduce chronic inflammation. Our central hypothesis is that short and long-term consumption of low-fat dairy yogurt will reduce inflammation to a greater extent in obese individuals by improving intestinal barrier function.

Conditions

Interventions

OTHER

Low fat dairy yogurt

Consumption of 12 oz of low fat dairy yogurt daily for 9 weeks

OTHER

Soy pudding

Consumption of 12 oz of low fat soy pudding daily for 9 weeks.

Sponsors & Collaborators

  • Dairy Research Institute

    collaborator OTHER

  • University of Wisconsin, Madison

    lead OTHER

Principal Investigators

  • Bradley W Bolling, PhD · University of Wisconsin, Madison

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2016-09-30
Completion
2017-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01686204 on ClinicalTrials.gov